Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging...
CyberThink in Action: 3 Digital Strategies for Medical Affairs
Everyone is talking about how Medical Affairs needs to evolve and innovate by being open-minded...
Leveraging Social Media to Transform Medical Affairs
This whitepaper explores the role of social media in enhancing Medical Affairs functions. As digital...
Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content
In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
Readability of published vs. artificial intelligence (AI)-generated plain-language summaries (PLS)
PLS play an important role in increasing the accessibility of medical publications to a wide...
Use of audiovisual data dissemination formats (ADDFs) by medical journals: then and now
GPP 2022 guidelines endorse the use of alternative data dissemination formats, including ADDFs, to enhance...